Geographic Differences in Endovascular Treatment and Retreatment of Cerebral Aneurysms

References

1. 1.↵
   2. Molyneux A,
   3. Kerr R,
   4. Stratton I, et al

   . International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 2002;360:1267–74 doi:10.1016/S0140-6736(02)11314-6 pmid:12414200

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Molyneux AJ,
   3. Kerr RS,
   4. Birks J, et al

   . Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial (ISAT): long-term follow-up. Lancet Neurol 2009;8:427–33 doi:10.1016/S1474-4422(09)70080-8 pmid:19329361

   CrossRefPubMedWeb of Science
3. 3.↵
   2. McDougall CG,
   3. Spetzler RF,
   4. Zabramski JM, et al

   . The Barrow Ruptured Aneurysm Trial. J Neurosurg 2012;116:135–44 doi:10.3171/2011.8.JNS101767 pmid:22054213

   CrossRefPubMedWeb of Science
4. 4.↵
   2. McDougall CG,
   3. Claiborne Johnston S,
   4. Gholkar A, et al

   . Bioactive versus bare platinum coils in the treatment of intracranial aneurysms: the MAPS (Matrix and Platinum Science) trial. AJNR Am J Neuroradiol 2014;35:935–42 doi:10.3174/ajnr.A3857 pmid:24481333

   Abstract/FREE Full Text
5. 5.↵
   2. Molyneux AJ,
   3. Clarke A,
   4. Sneade M, et al

   . Cerecyte coil trial: angiographic outcomes of a prospective randomized trial comparing endovascular coiling of cerebral aneurysms with either Cerecyte or bare platinum coils. Stroke 2012;43:2544–50 doi:10.1161/STROKEAHA.112.657254 pmid:22836352

   Abstract/FREE Full Text
6. 6.↵
   2. White PM,
   3. Lewis SC,
   4. Gholkar A, et al

   . Hydrogel-coated coils versus bare platinum coils for the endovascular treatment of intracranial aneurysms (HELPS): a randomised controlled trial. Lancet 2011;377:1655–62 doi:10.1016/S0140-6736(11)60408-X pmid:21571149

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Naggara ON,
   3. Lecler A,
   4. Oppenheim C, et al

   . Endovascular treatment of intracranial unruptured aneurysms: a systematic review of the literature on safety with emphasis on subgroup analyses. Radiology 2012;263:828–35 doi:10.1148/radiol.12112114 pmid:22623696

   CrossRefPubMedWeb of Science
8. 8.↵
   2. McDougall CG,
   3. Johnston SC,
   4. Gholkar A, et al

   . Counterpoint-target aneurysm recurrence: measuring what matters. AJNR Am J Neuroradiol 2015;36:4–6 doi:10.3174/ajnr.A4205 pmid:25430860

   FREE Full Text
9. 9.↵
   2. Pierot L,
   3. Fiehler J,
   4. White P

   . Point-TAR: a useful index to follow-up coiled intracranial aneurysms? AJNR Am J Neuroradiol 2015;36:2–4 doi:10.3174/ajnr.A4119 pmid:25300983

   FREE Full Text
10. 10.↵
    2. Raymond J,
    3. Guilbert F,
    4. Weill A, et al

    . Long-term angiographic recurrences after selective endovascular treatment of aneurysms with detachable coils. Stroke 2003;34:1398–403 doi:10.1161/01.STR.0000073841.88563.E9 pmid:25300983

    Abstract/FREE Full Text
11. 11.↵
    2. Hetts SW,
    3. Turk A,
    4. English JD, et al

    . Stent-assisted coiling versus coiling alone in unruptured intracranial aneurysms in the Matrix and Platinum Science trial: safety, efficacy, and mid-term outcomes. AJNR Am J Neuroradiol 2014;35:698–705 doi:10.3174/ajnr.A3755 pmid:24184523

    Abstract/FREE Full Text